Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 1976 (miR-1976) is a small, non-coding RNA molecule, 20 nucleotides in length, that regulates gene expression by binding to complementary sequences on target mRNAs and disrupting their translation or leading to their degradation[1][2]. It is located on chromosome 1p36.11 in humans[2]. miR-1976 has been implicated in neuronal apoptosis through targeting the PINK1 signaling pathway and may play a crucial role in the pathology of Parkinson’s disease[2]. In cancer, its downregulation has been associated with progression in breast and lung cancer, where it appears to act as a tumor suppressor; low levels may promote epithelial-mesenchymal transition and cancer metastasis[4][5]. miR-1976 is detectable in biofluids and may serve as a biomarker for certain diseases[2][5]. No approved drugs directly target miR-1976, but oligonucleotide-based approaches (anti-miRs or mimics) are under investigation as experimental therapeutic strategies[5].
Oligonucleotide-based antagonists ("antagomirs") can inhibit miR-1976 function. miR-1976 mimics can increase its biological function leading to apoptosis or tumor suppression, depending on disease context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 1976 (miR-1976 or MIR1976).